PGY2 residents identified and resolved numerous clinically relevant MRPs. Patient-specific criteria can be utilized to target self-insured employer health plan patients who are likely to have clinically relevant MRPs.
High-intensity statin prescribing increased in patients with ASCVD after release of the ACC/AHA cholesterol guidelines. Our data indicate that national evidence-based guidelines may influence clinical practice in very high risk patients.
Rationale, aims and objectives
Transitions of care between healthcare facilities are associated with increased risk of adverse events and hospital readmissions. Previous studies employing pharmacists in transitions of care showed reduced 30‐day readmissions, however, many were without an active comparator. There is no standardized approach to pharmacist involvement in transitions of care services, making it difficult to ascertain where pharmacist expertise is most meaningful. This paper aims to compare the 30‐day hospital readmissions between an interprofessional hospital discharge visit (iHDV) with physician and pharmacist involvement to a non‐interprofessional HDV (PHDV) without pharmacist involvement.
Method
This was a retrospective quality improvement initiative examining patients of two outpatient clinical practices within a large, academic medical centre. The primary analysis compared 30‐day hospital readmission rates for patients with a scheduled PHDV or iHDV within 30‐days of index hospital discharge date, regardless of attendance at the HDV. The secondary outcome compared 30‐day hospital readmission rates for patients who completed a PHDV or iHDV. Primary and secondary outcomes were evaluated using bivariate analysis and multivariate analysis by stepwise logistic regression, for both intention‐to‐treat (ITT) and per protocol (PP).
Results
This study found significantly lower 30‐day hospital readmissions for patients scheduled for a PHDV compared to an iHDV (16.7% vs 21.5%, P = .0230) in an unadjusted analysis, but no significant difference in adjusted analyses (P = .4856). Per‐protocol analysis found no significant difference in 30‐day hospital readmission rates between groups in unadjusted and adjusted analyses. Visit completion rates were significantly different between groups, with approximately twice as many PHDV group patients completing visits as compared to the iHDV group (74.1% vs 61.5%, P < .0001).
Conclusion
This study demonstrates an interprofessional clinic visit employing a clinical pharmacist in the post‐hospital discharge visit did not significantly reduce 30‐day hospital readmission rates compared to a post‐hospital discharge visit without pharmacist involvement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.